Michael Murray, MD
Otolaryngology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 7 carriers
- Offices
- 6
Offices
6 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plans that list them
30 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Murray’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A79157 · Current
Licensed to practise in California · since 2002 · expires 2027-08-31 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA2.24% owner since 2008 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA2.24% owner since 2008 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$146,086
Medicare paid this office $146,086 for 322 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of cochlear device | 22 | $26,532 | $1,154 |
| Short return visit (20+ min) | 132 | $22,042 | $84 |
| Return visit (30+ min) | 103 | $16,933 | $118 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 22 | $8,140 | $226 |
| New patient visit (45+ min) | 46 | $7,100 | $154 |
See all 18 services
| Insertion of cochlear device | 22 | $26,532 | $1,154 |
| Short return visit (20+ min) | 132 | $22,042 | $84 |
| Return visit (30+ min) | 103 | $16,933 | $118 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 22 | $8,140 | $226 |
| New patient visit (45+ min) | 46 | $7,100 | $154 |
| Comprehensive hearing and speech recognition test | 101 | $3,547 | $33 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 22 | $2,417 | $29 |
| Exam of ear using a microscope | 51 | $2,181 | $29 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 15 | $1,968 | $89 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 12 | $1,513 | $84 |
| Short return visit | 16 | $1,181 | $56 |
| Test to assess middle ear function | 72 | $1,172 | $16 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 40 | $1,152 | $29 |
| Removal of inflamed or infected skin, up to 10% of body surface | 19 | $1,152 | $58 |
| New patient visit (30+ min) | 11 | $804 | $73 |
| Removal of impacted ear wax | 14 | $796 | $47 |
| Test for eardrum and muscle function | 32 | $660 | $21 |
| Placement of skin electrodes and measurement of stimulated sites in trunk or head | 22 | $548 | $25 |
Procedures Medicare counted
| Removal of tissue | 24 | More than 71% of doctors who do this |
Who their Medicare patients are
322 Original Medicare patients in 2024. Average age 76 · Women 56% · Also on Medicaid 4% · Health risk score 1.00. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 71% · Coronary heart disease 29% · Diabetes 27% · Chronic kidney disease 18% · Cancer 15% · Atrial fibrillation 15% · Depression 13% · Heart failure 11% · COPD 10% · Stroke 10% · Dementia 5%.
The office billed $558,636, Medicare allowed $187,282 and paid $146,086; for 1,178 services of 62 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 322 | 1,178 | 76 | 1.00 | $558,636 | $146,086 |
| 2023 | 519 | 1,611 | 76 | 1.00 | $752,117 | $190,824 |
| 2022 | 1,019 | 3,147 | 77 | 1.03 | $1,093,692 | $283,036 |
| 2021 | 632 | 1,769 | 75 | 0.99 | $779,606 | $207,983 |
| 2020 | 434 | 1,447 | 75 | 1.05 | $556,832 | $138,406 |
| 2019 | 349 | 1,159 | 74 | 0.96 | $459,757 | $119,230 |
| 2018 | 335 | 1,165 | 75 | 1.06 | $421,517 | $108,138 |
| 2017 | 450 | 1,841 | 75 | 1.05 | $554,392 | $146,992 |
| 2016 | 241 | 891 | 74 | 0.86 | $239,684 | $97,992 |
| 2015 | 314 | 1,123 | 74 | 0.94 | $262,706 | $110,226 |
| 2014 | 277 | 1,071 | 74 | 0.94 | $238,073 | $100,559 |
| 2013 | 152 | 697 | 73 | 0.90 | $145,656 | $65,143 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Short return visit (20+ min) | 256 | $34,130 | $80 |
| Return visit (30+ min) | 168 | $27,417 | $113 |
| New patient visit (45+ min) | 141 | $18,429 | $131 |
| Insertion of cochlear device | 14 | $16,125 | $1,152 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 32 | $13,248 | $221 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | $6,710 | $132 |
| Removal of impacted ear wax | 135 | $6,159 | $40 |
| New patient visit (60+ min) | 26 | $4,681 | $180 |
| Long return visit (40+ min) | 25 | $4,027 | $155 |
| Exam of ear using a microscope | 67 | $3,370 | $29 |
| Removal of inflamed or infected skin, up to 10% of body surface | 23 | $2,232 | $56 |
| Comprehensive hearing and speech recognition test | 51 | $1,661 | $33 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 13 | $1,529 | $29 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 23 | $668 | $29 |
| Test to assess middle ear function | 32 | $482 | $15 |
| Test for eardrum and muscle function | 22 | $431 | $20 |
2022: 21 services
| Short return visit (20+ min) | 499 | $68,160 | $80 |
| New patient visit (45+ min) | 291 | $37,931 | $130 |
| Return visit (30+ min) | 171 | $27,255 | $113 |
| Insertion of cochlear device | 18 | $20,964 | $1,165 |
| Diagnostic exam of voice box using a flexible endoscope | 86 | $14,817 | $131 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 31 | $12,664 | $235 |
| Comprehensive hearing and speech recognition test | 279 | $10,279 | $35 |
| Removal of impacted ear wax | 203 | $9,770 | $40 |
| New patient visit (30+ min) | 92 | $8,746 | $95 |
| New patient visit (60+ min) | 33 | $6,582 | $199 |
| Exam of ear using a microscope | 116 | $5,456 | $29 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 146 | $4,636 | $32 |
| Removal of inflamed or infected skin, up to 10% of body surface | 40 | $3,418 | $55 |
| Test for eardrum and muscle function | 139 | $2,932 | $21 |
| Test to assess middle ear function | 147 | $2,512 | $16 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 20 | $2,412 | $86 |
| Long return visit (40+ min) | 14 | $2,403 | $172 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $2,282 | $190 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 17 | $1,877 | $82 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 | $814 | $48 |
| Short return visit | 15 | $791 | $47 |
2021: 12 services
| Short return visit (20+ min) | 319 | $43,212 | $84 |
| New patient visit (45+ min) | 227 | $33,766 | $149 |
| Return visit (30+ min) | 187 | $30,552 | $120 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $9,513 | $125 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 21 | $8,718 | $229 |
| Removal of impacted ear wax | 133 | $6,616 | $42 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $5,315 | $204 |
| New patient visit (30+ min) | 55 | $4,952 | $90 |
| Exam of ear using a microscope | 85 | $3,924 | $30 |
| New patient visit (60+ min) | 14 | $2,934 | $210 |
| Removal of inflamed or infected skin, up to 10% of body surface | 23 | $2,511 | $57 |
| Short return visit | 31 | $1,834 | $51 |
2020: 17 services
| Short return visit (20+ min) | 209 | $24,100 | $69 |
| Return visit (30+ min) | 152 | $20,080 | $101 |
| New patient visit (45+ min) | 64 | $8,847 | $138 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 20 | $6,335 | $218 |
| New patient visit (30+ min) | 67 | $5,661 | $84 |
| Removal of impacted ear wax | 107 | $5,368 | $42 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $5,180 | $110 |
| Exam of ear using a microscope | 85 | $4,507 | $30 |
| Removal of inflamed or infected skin, up to 10% of body surface | 30 | $3,436 | $57 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $2,925 | $183 |
| New patient visit (60+ min) | 15 | $2,839 | $189 |
| Long return visit (40+ min) | 17 | $2,244 | $125 |
| Short return visit | 31 | $1,994 | $44 |
| Comprehensive hearing and speech recognition test | 39 | $1,246 | $28 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 19 | $538 | $28 |
| Test to assess middle ear function | 25 | $380 | $13 |
| Test for eardrum and muscle function | 15 | $269 | $18 |
2019: 16 services
| Short return visit (20+ min) | 181 | $20,629 | $66 |
| Return visit (30+ min) | 113 | $13,756 | $98 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 25 | $7,271 | $214 |
| New patient visit (45+ min) | 41 | $6,022 | $147 |
| Diagnostic exam of nasal passages using an endoscope | 20 | $5,428 | $201 |
| Diagnostic exam of voice box using a flexible endoscope | 37 | $5,241 | $112 |
| New patient visit (30+ min) | 48 | $4,561 | $95 |
| Exam of ear using a microscope | 71 | $2,992 | $30 |
| Removal of impacted ear wax | 48 | $2,247 | $40 |
| Long return visit (40+ min) | 13 | $1,789 | $138 |
| Removal of inflamed or infected skin, up to 10% of body surface | 26 | $1,717 | $51 |
| Comprehensive hearing and speech recognition test | 48 | $1,486 | $27 |
| Short return visit | 20 | $1,015 | $42 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 33 | $880 | $27 |
| Test for eardrum and muscle function | 24 | $420 | $17 |
| Test to assess middle ear function | 29 | $396 | $11 |
2018: 18 services
| Short return visit (20+ min) | 135 | $15,704 | $62 |
| Return visit (30+ min) | 99 | $11,865 | $96 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 26 | $9,617 | $219 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $4,406 | $192 |
| New patient visit (45+ min) | 30 | $3,953 | $132 |
| Exam of ear using a microscope | 73 | $3,127 | $28 |
| New patient visit (60+ min) | 16 | $2,971 | $186 |
| Comprehensive hearing and speech recognition test | 91 | $2,803 | $30 |
| Removal of inflamed or infected skin, up to 10% of body surface | 32 | $2,532 | $50 |
| Long return visit (40+ min) | 17 | $2,382 | $132 |
| New patient visit (30+ min) | 25 | $2,149 | $86 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 22 | $1,797 | $75 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 59 | $1,662 | $28 |
| Removal of impacted ear wax | 29 | $1,388 | $39 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 15 | $1,334 | $74 |
| Short return visit | 24 | $1,323 | $40 |
| Test for eardrum and muscle function | 54 | $1,017 | $19 |
| Test to assess middle ear function | 37 | $442 | $12 |
2017: 21 services
| Short return visit (20+ min) | 170 | $20,895 | $64 |
| Return visit (30+ min) | 91 | $10,047 | $88 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 37 | $9,443 | $210 |
| Comprehensive hearing and speech recognition test | 219 | $8,242 | $34 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $7,929 | $198 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 13 | $5,630 | $296 |
| Exam of ear using a microscope | 86 | $4,308 | $28 |
| New patient visit (30+ min) | 45 | $4,183 | $93 |
| New patient visit (45+ min) | 32 | $4,060 | $127 |
| New patient visit (60+ min) | 22 | $3,698 | $168 |
| Long return visit (40+ min) | 22 | $3,072 | $128 |
| Removal of inflamed or infected skin, up to 10% of body surface | 43 | $3,018 | $48 |
| Test for eardrum and muscle function | 136 | $2,613 | $19 |
| Removal of impacted ear wax | 61 | $2,611 | $40 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 13 | $2,230 | $83 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 17 | $2,058 | $82 |
| Short return visit | 31 | $1,920 | $40 |
| Placement of ear probe for computerized measurement of sound with interpretation and report | 98 | $1,914 | $19 |
| Test to assess middle ear function | 98 | $1,423 | $13 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 47 | $1,405 | $30 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 11 | $534 | $49 |
2016: 11 services
| Short return visit (20+ min) | 133 | $16,381 | $62 |
| Return visit (30+ min) | 72 | $7,635 | $93 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 20 | $6,411 | $207 |
| New patient visit (45+ min) | 46 | $6,215 | $135 |
| Exam of ear using a microscope | 102 | $5,905 | $28 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $5,078 | $203 |
| Exam of the nose and throat using an endoscope | 22 | $2,587 | $112 |
| New patient visit (60+ min) | 13 | $2,345 | $180 |
| Removal of inflamed or infected skin, up to 10% of body surface | 23 | $2,199 | $50 |
| New patient visit (30+ min) | 22 | $2,015 | $92 |
| Short return visit | 11 | $815 | $41 |
2015: 11 services
| Short return visit (20+ min) | 179 | $19,050 | $60 |
| New patient visit (45+ min) | 67 | $9,631 | $144 |
| Return visit (30+ min) | 76 | $9,519 | $96 |
| Exam of ear using a microscope | 161 | $7,835 | $28 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 20 | $6,261 | $216 |
| Removal of inflamed or infected skin, up to 10% of body surface | 37 | $3,323 | $50 |
| New patient visit (60+ min) | 17 | $3,180 | $187 |
| New patient visit (30+ min) | 37 | $2,985 | $81 |
| Diagnostic exam of nasal passages using an endoscope | 11 | $2,842 | $203 |
| Exam of the nose and throat using an endoscope | 15 | $2,668 | $133 |
| Short return visit | 33 | $2,248 | $36 |
2014: 11 services
| Short return visit (20+ min) | 162 | $16,254 | $63 |
| New patient visit (45+ min) | 65 | $9,487 | $146 |
| Exam of ear using a microscope | 156 | $8,176 | $29 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 18 | $5,644 | $217 |
| Return visit (30+ min) | 44 | $4,304 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $4,293 | $204 |
| Short return visit | 63 | $4,173 | $38 |
| Removal of inflamed or infected skin, up to 10% of body surface | 42 | $3,787 | $50 |
| New patient visit (30+ min) | 36 | $3,428 | $95 |
| New patient visit (60+ min) | 15 | $2,776 | $185 |
| Exam of the nose and throat using an endoscope | 15 | $2,385 | $140 |
2013: 9 services
| Short return visit (20+ min) | 91 | $10,723 | $62 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $7,070 | $214 |
| Exam of ear using a microscope | 107 | $6,324 | $30 |
| Return visit (30+ min) | 30 | $3,741 | $94 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 14 | $3,535 | $221 |
| New patient visit (45+ min) | 24 | $3,287 | $137 |
| Short return visit | 42 | $2,946 | $38 |
| Removal of inflamed or infected skin, up to 10% of body surface | 21 | $2,146 | $52 |
| New patient visit (30+ min) | 13 | $1,249 | $96 |
Drugs they prescribed that Part D paid
$7,922
Pharmacies billed $7,922 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (40 of 303) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
290 generic and 13 brand-name prescriptions · $7,922 in drug cost · 34 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofloxacin | 57 | $2,265 | $40 |
| Tobramycin-Dexamethasone | 18 | $1,326 | $74 |
| Oxycodone-Acetaminophen | 39 | $522 | $13 |
| Triamterene-Hydrochlorothiazid | 32 | $520 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $270 | $23 |
See all 7 drugs
| Ofloxacin | 57 | $2,265 | $40 |
| Tobramycin-Dexamethasone | 18 | $1,326 | $74 |
| Oxycodone-Acetaminophen | 39 | $522 | $13 |
| Triamterene-Hydrochlorothiazid | 32 | $520 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $270 | $23 |
| Montelukast | 19 | $268 | $14 |
| Ondansetron | 42 | $131 | $3 |
Year by year
| 2024 | 303 | 102 | 13% (40) | 4% | $7,922 |
| 2023 | 264 | 100 | 9% (23) | None | $8,736 |
| 2022 | 285 | 111 | 11% (31) | None | $8,412 |
| 2021 | 260 | 96 | 7% (17) | None | $9,105 |
| 2020 | 253 | 88 | 5% (12) | 5% | $10,368 |
| 2019 | 241 | 88 | 6% (14) | 9% | $11,868 |
| 2018 | 223 | 80 | None | 14% | $14,562 |
| 2017 | 257 | 86 | 6% (16) | 11% | $14,324 |
| 2016 | 296 | 126 | 5% (14) | 14% | $15,284 |
| 2015 | 303 | 102 | 5% (16) | 15% | $19,659 |
| 2014 | 282 | 101 | 8% (22) | 26% | $15,687 |
| 2013 | 203 | 62 | 6% (12) | 29% | $12,089 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Ofloxacin | 58 | $3,805 | $66 |
| Tobramycin-Dexamethasone | 17 | $1,012 | $60 |
| Triamterene-Hydrochlorothiazid | 44 | $837 | $19 |
| Montelukast | 23 | $299 | $13 |
| Oxycodone-Acetaminophen | 21 | $161 | $8 |
2022: 8 drugs
| Ofloxacin | 35 | $3,020 | $86 |
| Triamterene-Hydrochlorothiazid | 39 | $625 | $16 |
| Montelukast | 33 | $493 | $15 |
| Oxycodone-Acetaminophen | 31 | $277 | $9 |
| Gabapentin | 12 | $240 | $20 |
| Fluticasone Propionate | 15 | $152 | $10 |
| Hydroxyzine | 12 | $76 | $6 |
| Lorazepam | 13 | $31 | $2 |
2021: 9 drugs
| Azelastine-Fluticasone | 11 | $1,951 | $177 |
| Ofloxacin | 35 | $1,912 | $55 |
| Montelukast | 34 | $677 | $20 |
| Triamterene-Hydrochlorothiazid | 36 | $668 | $19 |
| Azelastine | 19 | $461 | $24 |
| Ipratropium | 14 | $318 | $23 |
| Fluticasone Propionate | 14 | $267 | $19 |
| Oxycodone-Acetaminophen | 17 | $133 | $8 |
| Lorazepam | 12 | $33 | $3 |
2020: 7 drugs
| Ofloxacin | 24 | $1,355 | $56 |
| Triamterene-Hydrochlorothiazid | 47 | $833 | $18 |
| Azelastine | 20 | $782 | $39 |
| Montelukast | 36 | $590 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $128 | $11 |
| Oxycodone-Acetaminophen | 12 | $91 | $8 |
| Lorazepam | 12 | $78 | $7 |
2019: 7 drugs
| Ofloxacin | 37 | $2,737 | $74 |
| Azelastine | 22 | $1,081 | $49 |
| Triamterene-Hydrochlorothiazid | 43 | $509 | $12 |
| Montelukast | 21 | $466 | $22 |
| Oxycodone-Acetaminophen | 13 | $104 | $8 |
| Mupirocin | 13 | $87 | $7 |
| Lorazepam | 12 | $69 | $6 |
2018: 7 drugs
| Ciprodex | 16 | $3,779 | $236 |
| Ofloxacin | 21 | $1,983 | $94 |
| Azelastine | 16 | $944 | $59 |
| Montelukast | 23 | $362 | $16 |
| Triamterene-Hydrochlorothiazid | 25 | $279 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $100 | $8 |
| Azithromycin | 14 | $95 | $7 |
2017: 8 drugs
| Ofloxacin | 33 | $2,747 | $83 |
| Ciprodex | 13 | $2,650 | $204 |
| Azelastine | 16 | $747 | $47 |
| Triamterene-Hydrochlorothiazid | 40 | $397 | $10 |
| Montelukast | 12 | $201 | $17 |
| Ipratropium | 14 | $182 | $13 |
| Methylprednisolone | 12 | $182 | $15 |
| Oxycodone-Acetaminophen | 16 | $104 | $6 |
2016: 7 drugs
| Nasonex | 11 | $2,664 | $242 |
| Ofloxacin | 55 | $2,270 | $41 |
| Triamterene-Hydrochlorothiazid | 51 | $510 | $10 |
| Fluticasone Propionate | 17 | $324 | $19 |
| Montelukast | 14 | $297 | $21 |
| Amoxicillin-Clavulanate Potass | 18 | $265 | $15 |
| Oxycodone-Acetaminophen | 13 | $225 | $17 |
2015: 8 drugs
| Ofloxacin | 63 | $5,111 | $81 |
| Nasonex | 15 | $4,553 | $304 |
| Dymista | 11 | $1,861 | $169 |
| Fluticasone Propionate | 39 | $536 | $14 |
| Hydroxyzine | 12 | $388 | $32 |
| Triamterene-Hydrochlorothiazid | 28 | $279 | $10 |
| Oxycodone-Acetaminophen | 14 | $186 | $13 |
| Montelukast | 11 | $172 | $16 |
2014: 8 drugs
| Nasonex | 22 | $3,849 | $175 |
| Ciprodex | 22 | $3,514 | $160 |
| Ofloxacin | 33 | $766 | $23 |
| Montelukast | 24 | $436 | $18 |
| Fluticasone Propionate | 24 | $303 | $13 |
| Triamterene-Hydrochlorothiazid | 18 | $183 | $10 |
| Hydrocodone-Acetaminophen | 15 | $134 | $9 |
| Azithromycin | 11 | $83 | $8 |
2013: 8 drugs
| Nasonex | 26 | $4,618 | $178 |
| Ciprodex | 11 | $1,615 | $147 |
| Montelukast | 21 | $762 | $36 |
| Fluticasone Propionate | 13 | $429 | $33 |
| Omeprazole | 17 | $391 | $23 |
| Ofloxacin | 19 | $323 | $17 |
| Sulfamethoxazole-Trimethoprim | 12 | $126 | $11 |
| Hydrocodone-Acetaminophen | 12 | $73 | $6 |
Money from drug and device companies
$90 in 2025
| 2025 | 1 | 1 | None | $90 |
| 2024 | 3 | 4 | None | $168 |
| 2023 | 1 | 2 | None | $115 |
| 2022 | 2 | 5 | None | $291 |
| 2021 | 4 | 5 | None | $141 |
| 2019 | 5 | 21 | $3,000 | $6,476 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $90 | 1 payment
|
See the published payment
| Cochlear Americas | Meals · 2025-04-24 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $90 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $168
| Med-El | Mi1250 Synchrony 2 Flexsoft | $72 | 1 payment
|
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $65 | 2 payments
|
| Smith+Nephew | Tula | $32 | 1 payment
|
2023: $115
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $115 | 2 payments
|
2022: $291
| Advanced Bionics | Hires Ultra Ci Hifocus Ms Electrode | $172 | 4 payments
|
| Cochlear Americas | Cochlear | $119 | 1 payment
|
2021: $141
| Advanced Bionics | Hires Ultra Ci Hifocus Ms Electrode | $86 | 2 payments
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Med-El | Med-El Maestro Cochlear Implant System | $19 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $12 | 1 payment
|
2019: $6,476
| Med-El | Med-El Maestro Cochlear Implant System | $6,366 | 12 payments
|
| Smith+Nephew | Coblation Wands | $44 | 1 payment
|
| Cochlear Americas | Nucleus | $30 | 1 payment
|
| Intersect ENT | Sinuva | $24 | 1 payment
|
| Agiliti Surgical | None | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Smith+Nephew, Inc. · Otter Pivotal Study · 2020 | Their institution | $772 |
| Smith+Nephew, Inc. · Otter Pivotal Study · 2021 | Their institution | $355 |
Checkups this office reported
18 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 85% | 20 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 11%That's few of the people this applied to. | 28 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 49%That's less than half. | 188 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 1%That's few of the people this applied to. Better on this measure. | 124 |
| Breast cancer screeningEligible women who got a mammogram | 32%That's less than half. | 387 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 19%That's few of the people this applied to. | 539 |
| Checked for fall riskOlder patients screened for fall risk | 13%That's few of the people this applied to. | 640 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 0% | 23 |
See the other 10 measures
| Colon cancer screeningEligible adults who got a colon cancer test | 18%That's few of the people this applied to. | 887 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 5%That's few of the people this applied to. | 1,846 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 8%That's few of the people this applied to. | 38 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 58%That's more than half. Worse on this measure. | 38 |
| HIV screeningEligible patients who were screened for HIV | 12%That's few of the people this applied to. | 1,314 |
| Medications listed in the chartVisits where the current medication list was documented | 85%That's most of the people this applied to. | 3,898 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 89%That's most of the people this applied to. | 482 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 255 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 74%That's more than half. | 223 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 33%That's less than half. | 1,868 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1750475828
- Licence
- CA A79157California A79157: Current · expires 2027-08-31
- Trained
- University of Minnesota Medical School, 1997
- Group
- Bass Medical Group
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2577 Samaritan Dr Ste 765, San Jose, CA, 95124
- NPI first listed
- 2006-10-03
- NPI last updated
- 2025-03-03
- NPI record certified
- 2025-03-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6060 Hellyer Ave, San Jose, CA, 95138